✦ LIBER ✦

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial

✍ Scribed by Hansen, Ditte; Rasmussen, Knud; Danielsen, Henning; Meyer-Hofmann, Helmut; Bacevicius, Egidijus; Lauridsen, Thomas G; Madsen, Jens K; Tougaard, Birgitte G; Marckmann, Peter; Thye-Roenn, Peter; Nielsen, Jørgen E; Kreiner, Svend; Brandi, Lisbet

Book ID: 121433136
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 354 KB
Volume: 80
Category: Article
ISSN: 0085-2538
DOI: 10.1038/ki.2011.226

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial comparing pulse calcitr

Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients

✍ KRAIWIPORN KIATTISUNTHORN; KITTIKARN WUTYAM; ARTIT INDRANOI; SOMKIAT VASUVATTAKU 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Oral Paricalcitol in the Treatment of Pa

Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial

✍ Steven Fishbane; Harini Chittineni; Michal Packman; Paula Dutka; Nicole Ali; Nic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Randomized controlled trial to compare t

Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism

✍ Ong, Loke Meng; Narayanan, Punithavathi; Goh, Heong Keong; Manocha, Anita Bhajan 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Effects of 22-Oxacalcitriol and Calcitri

Effects of 22-Oxacalcitriol and Calcitriol on PTH Secretion and Bone Mineral Metabolism in a Crossover Trial in Hemodialysis Patients With Secondary Hyperparathyroidism

✍ Hiroaki Ogata; Fumihiko Koiwa; Kanji Shishido; Keiko Takahashi; Hidetoshi Ito; E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

141 Baseline Characteristics of Subjects

141 Baseline Characteristics of Subjects in Impact-Shpt: A Study to Evaluate the Efficacy and Safety of Paricalcitol and Cinacalcet in Hemodialysis Patients With Secondary Hyperparathyroidism

✍ Markus Ketteler; Kevin Martin; Mario Cozzolino; David Goldsmith; Amit Sharma; My 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Early Initiation of Cinacalcet for the T

Early Initiation of Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A Three-Year Clinical Experience

✍ Leonardo Lucchi; Chiara Carboni; Lucia Stipo; Vittoria Malaguti; Federica Ferrar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB